Date Filed | Type | Description |
10/03/2023 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Paid exercise price by delivering 2,624 shares
@ $0.6199, valued at
$1.6k
Exercised 8,953 restricted stock units
@ $0 |
|
07/03/2023 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Paid exercise price by delivering 4,057 shares
@ $0.855, valued at
$3.5k
Exercised 13,841 restricted stock units
@ $0 |
|
04/04/2023 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Paid exercise price by delivering 1,154 shares
@ $1.39, valued at
$1.6k
Exercised 4,063 restricted stock units
@ $0 |
|
02/03/2023 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Granted 102,688 options
@ $3.16, valued at
$324.5k
Granted 78,234 restricted stock units
@ $0 |
|
01/03/2023 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Paid exercise price by delivering 1,406 shares
@ $2.37, valued at
$3.3k
Exercised 4,062 restricted stock units
@ $0 |
|
11/16/2022 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Bought 6,053 shares
@ $3, valued at
$18.2k
Bought 10,000 shares
@ $3.15, valued at
$31.5k
|
|
10/03/2022 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Paid exercise price by delivering 1,191 shares
@ $1.52, valued at
$1.8k
Exercised 4,063 restricted stock units
@ $0 |
|
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Cittadine Andrew (COO) has filed a Form 4 on Monopar Therapeutics
Txns:
| Granted 85,000 options
@ $2.8, valued at
$238k
Granted 65,000 restricted stock units
@ $0 |
|
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
06/01/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |